An Indispensible Parameters of Dilated Cardio Myopathy Include Etiology Include Etiology, Epidemiology, Patho Physiology, Diagnosis, Differential Diagnosis, Treatment, Prognosis, Complications and Health Care Outcomes
Abstract
References
Hershberger, R. E., & Jordan, E. (2007, July 27). Dilated cardiomyopathy overview. In M. P. Adam, J. Feldman, G. M. Mirzaa, R. A. Pagon, S. E. Wallace, A. Amemiya, et al. (Eds.), GeneReviews® [Internet]. University of Washington, Seattle. https://www.ncbi.nlm.nih.gov/books/NBK1309/
Stergiopoulos, K., & Lima, F. V. (2019). Peripartum cardiomyopathy—Diagnosis, management, and long-term implications. Trends in Cardiovascular Medicine, 29(3), 164–173. https://doi.org/10.1016/j.tcm.2018.07.007
Paldino, A., De Angelis, G., Merlo, M., Gigli, M., Dal Ferro, M., Severini, G. M., Mestroni, L., & Sinagra, G. (2018). Genetics of dilated cardiomyopathy: Clinical implications. Current Cardiology Reports, 20(10), 83. https://doi.org/10.1007/s11886-018-1036-0
Vikhorev, P. G., & Vikhoreva, N. N. (2018). Cardiomyopathies and related changes in contractility of human heart muscle. International Journal of Molecular Sciences, 19(8), 2415. https://doi.org/10.3390/ijms19082415
Masarone, D., Kaski, J. P., Pacileo, G., Elliott, P. M., Bossone, E., Day, S. M., & Limongelli, G. (2018). Epidemiology and clinical aspects of genetic cardiomyopathies. Heart Failure Clinics, 14(2), 119–128. https://doi.org/10.1016/j.hfc.2017.11.003
Bakalakos, A., Ritsatos, K., & Anastasakis, A. (2018). Current perspectives on the diagnosis and management of dilated cardiomyopathy beyond heart failure: A Cardiomyopathy Clinic doctor’s point of view. Hellenic Journal of Cardiology, 59(5), 254–261. https://doi.org/10.1016/j.hjc.2018.02.005
Palomer, X., Pizarro-Delgado, J., & Vázquez-Carrera, M. (2018). Emerging actors in diabetic cardiomyopathy: Heartbreaker biomarkers or therapeutic targets? Trends in Pharmacological Sciences, 39(5), 452–467. https://doi.org/10.1016/j.tips.2018.02.007
Dainis, A. M., & Ashley, E. A. (2018). Cardiovascular precision medicine in the genomics era. JACC: Basic to Translational Science, 3(2), 313–326. https://doi.org/10.1016/j.jacbts.2018.01.002
Mu, M., Majoni, S. W., Iyngkaran, P., Haste, M., & Kangaharan, N. (2019). Adherence to treatment guidelines in heart failure patients in the Top End region of Northern Territory. Heart, Lung and Circulation, 28(7), 1042–1049. https://doi.org/10.1016/j.hlc.2018.05.211
Bertini, M., Balla, C., Pavasini, R., & Boriani, G. (2018). Efficacy of cardiac resynchronization therapy in patients with isolated ventricular noncompaction with dilated cardiomyopathy: A systematic review of the literature. Journal of Cardiovascular Medicine (Hagerstown), 19(7), 324–328. https://doi.org/10.2459/JCM.0000000000000663
Broch, K., Murbræch, K., Andreassen, A. K., Hopp, E., Aakhus, S., & Gullestad, L. (2015). Contemporary outcome in patients with idiopathic dilated cardiomyopathy. The American Journal of Cardiology, 116(6), 952–959. https://doi.org/10.1016/j.amjcard.2015.06.022
Caviedes Bottner, P., Córdova Fernández, T., Larraín Valenzuela, M., & Cruces Romero Presentación de Casos Clínicos, P. (2018). Dilated cardiomyopathy and severe heart failure: An update for pediatricians. Archivos Argentinos de Pediatría, 116(3), e421–e428. https://doi.org/10.5546/aap.2018.eng.e421
Refbacks
- There are currently no refbacks.